|
Dear Jill,
Below is what Thom Hale has in his
'medications and mother's milk' book please consider purchasing a copy (from
CAPERS) it is worth that ALL Midwives should have the latest copy with them
all the time.
Regards,
Anne Clarke
Brisbane
Propylthiouracil
Trade name PTU, Propyl-Thyracil
Uses - Antithyroid
Approved by the American Academy of Paediatrics for
use in breastfeeding mothers.
Propylthiouracil reduces the production and
secretion of thyroxine by the tyroid gland. Only small amounts are
secreted into breastmilk. Reports thus far suggest that levels absorbed by
infants are too low to produce side effects. In one study of nine patients
given 400 mg doses, mean serum and milk levels were 7.7 mg/L and 0.7/L
respectively, which correlated to only 0.025% of the maternal dose. No
changes in infant thyroid have been reported. PTU is the best of
antithyroid medicatins for use in lactating mothers. Monitor infant
thyroid function (T4, TSH) carefully during therapy.
Adult concerns: Hypothyroidism, liver
toxicity, aplastic aneamia, anaemia
Paediatric concerns: non reported, but
observed closely for thyroid function.
Drug interactions: activity of oral
anticoagulants may be potentiated by PTU associated anti-vitamin K
activity.
References:
1. Cooper DS Antithyroid drugs: to breastfeed or
not to breastfeed AM J Obstet Gynecol 157:234-235, 1987
2. Kampmann JP, et. al., Propylthiouracil in human
milk, Lancet1:736-8, 1980
|
- [ozmidwifery] graves disease and breastfeeding jireland
- Re: [ozmidwifery] graves disease and breastfeeding Joy Cocks
- Re: [ozmidwifery] graves disease and breastfeeding Anne Clarke
- Re: [ozmidwifery] graves disease and breastfeeding Anne Clarke
- Re: [ozmidwifery] graves disease and breastfeeding leanne wynne
